Response of resting human peripheral blood natural killer cells to interleukin 2
- PMID: 6434688
- PMCID: PMC2187474
- DOI: 10.1084/jem.160.4.1147
Response of resting human peripheral blood natural killer cells to interleukin 2
Abstract
The present study shows that recombinant interleukin 2 (IL-2) purified to homogeneity induces a rapid and potent enhancement of spontaneous cytotoxicity of human peripheral blood lymphocytes. The cells mediating cytotoxicity after 18-h treatment with IL-2 have surface markers of natural killer (NK) cells and are generated from the peripheral blood subset containing spontaneous cytotoxic cells. A parallel production of gamma interferon (IFN-gamma) is induced by recombinant IL-2 (rIL-2), and NK cells appear to be the major producer cells, whereas T cells are unable to produce IFN-gamma under these experimental conditions. However, the kinetics of the enhancement of cytotoxicity are faster than those of IFN-gamma production, and monoclonal anti-IFN-gamma antibodies do not suppress this effect, making it unlikely that the IFN-gamma produced is responsible for the enhancement. The enhancement of NK cell activity induced by rIL-2 precedes any proliferative response of the lymphocytes, which is instead observed in longer-term cultures of both NK and T cells.
Similar articles
-
Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).J Immunol. 1985 May;134(5):3124-9. J Immunol. 1985. PMID: 2984283
-
Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.J Immunol. 1986 Mar 1;136(5):1700-7. J Immunol. 1986. PMID: 3005399
-
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.J Immunol. 1985 Mar;134(3):1503-7. J Immunol. 1985. PMID: 3918102
-
[Symposium on mechanisms of host defense from fundamental and clinical medicine. 2. Role of natural killer (NK) cells and interferon in self-defense mechanisms].Nihon Naika Gakkai Zasshi. 1984 Dec;73(12):1747-51. doi: 10.2169/naika.73.1747. Nihon Naika Gakkai Zasshi. 1984. PMID: 6085342 Review. Japanese. No abstract available.
-
Gamma-interferon is produced by CD3+ and CD3- lymphocytes.Immunol Rev. 1987 Jun;97:51-65. doi: 10.1111/j.1600-065x.1987.tb00516.x. Immunol Rev. 1987. PMID: 3114127 Review. No abstract available.
Cited by
-
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.J Exp Med. 1990 Apr 1;171(4):1315-32. doi: 10.1084/jem.171.4.1315. J Exp Med. 1990. PMID: 2139102 Free PMC article.
-
Interleukin 2-induced proliferation of murine natural killer cells in vivo.J Exp Med. 1990 Jan 1;171(1):173-88. doi: 10.1084/jem.171.1.173. J Exp Med. 1990. PMID: 1688606 Free PMC article.
-
Heterogeneous lymphokine-activated killer cell precursor populations. Development of a monoclonal antibody that separates two populations of precursors with distinct culture requirements and separate target-recognition repertoires.Cancer Immunol Immunother. 1989;29(3):155-66. doi: 10.1007/BF00199990. Cancer Immunol Immunother. 1989. PMID: 2786456 Free PMC article.
-
Viral infection of vascular endothelial cells alters production of colony-stimulating activity.J Clin Invest. 1985 Oct;76(4):1382-90. doi: 10.1172/JCI112114. J Clin Invest. 1985. PMID: 2414319 Free PMC article.
-
Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.J Clin Immunol. 1986 May;6(3):216-24. doi: 10.1007/BF00918701. J Clin Immunol. 1986. PMID: 3013922
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources